The United Kingdom’s drug regulator approved the world’s ‘most expensive drug’ which is used to treat a rare genetic disorder. Manufactured by Novartis Gene Therapies, Zolgensma, has a list price of approximately USD $2.48 million per dose, the National Health Services England said. The medicine is used to treat Spinal Muscular Atrophy (SMA), a rare […]
